FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely ophthalmology, and can be used for treating diabetic macular retinopathy (DMR), particularly diabetic macular oedema. It involves laser infrared transpupillary thermotherapy that implies having a single exposure on an eye retina to subthreshold radiation of wave length 810 nm, in a micropulse mode, radiation power 500-2000 mWt, spot diameter 3-5 mm for 5-20 seconds. A working cycle of microimpulse enable in a micropulse mode is 10-20 %.
EFFECT: method allows improving visual acuity ensured by decreased macular thickness, eliminating risk of the intraoperative and remote complications, and also reducing length of treatment.
2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT DIABETIC MACULAR RETIMOPATHY | 2007 |
|
RU2340320C1 |
| METHOD OF COMBINED LASER TREATMENT OF DIABETIC MACULAR OEDEMA | 2015 |
|
RU2578371C1 |
| METHOD FOR COMBINATION THERAPY OF RETINOVASCULAR MACULAR OEDEMA | 2013 |
|
RU2527360C1 |
| METHOD FOR TARGETED TREATMENT OF DIABETIC MACULOPATHY WITH FOCAL DIABETIC MACULAR EDEMA USING NAVILAS 577S LASER | 2021 |
|
RU2752544C1 |
| METHOD OF DIFFERENTIATED APPROACH TO SURGICAL TREATMENT OF CHRONIC FORM OF CENTRAL SEROUS CHORIORETINOPATHY | 2024 |
|
RU2823160C1 |
| METHOD FOR COMPREHENSIVE TREATMENT OF MACULAR EDEMA ASSOCIATED WITH OCCLUSION OF BRANCH OF CENTRAL RETINAL VEIN WITH OCT CONTROL IN REAL TIME | 2019 |
|
RU2749122C1 |
| METHOD OF FUNCTIONAL-SAVING TREATMENT OF DIABETIC MACULOPATHY WITH FOCAL DIABETIC MACULAR EDEMA USING NAVILAS 577S LASER | 2022 |
|
RU2801485C1 |
| METHOD OF TREATMENT OF MACULAR FOR AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2647142C1 |
| COMPLEX METHOD OF MACULAR OEDEMA TREATMENT IN RETINAL VEIN OCCLUSIONS | 2019 |
|
RU2718847C1 |
| METHOD OF LASER TREATMENT OF FUSED DRUSEN IN CASE OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2472476C1 |
